Terrance McGuire is Director at IRONWOOD PHARMACEUTICALS INC (IRWD). They have made 22 open-market trades across 11 companies since 2009, most recently 2026-07-28.
CIK 0001117003
6 open-market purchases totalling $26.6M since 2017, against 16 sales. Across 6 scored buys the stock is down 21.1% at ninety days, and 27.6 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 33% | 0% |
| Avg Move | -16.3% | +5.7% | -21.1% |
| Alpha | -25.4% | +2.2% | -27.6% |
| Scored | 6 | 6 | 6 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 80% | 80% |
| Avg Move | -8.4% | -3.6% | -20.4% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TECX | SELL | 2025-04-07 | 2025-04-07 | $17.10 | $8.6M | +3.8% | +15.7% | +26.7% |
| IVVD | SELL | 2024-12-27 | 2024-12-31 | $0.48 | $132K | -13.9% | -17.0% | +28.8% |
| IVVD | SELL | 2024-12-20 | 2024-12-26 | $0.46 | $215K | -15.6% | -24.6% | +12.5% |
| IVVD | SELL | 2024-12-17 | 2024-12-19 | $0.45 | $213K | +14.3% | -3.0% | +71.4% |
| IVVD | SELL | 2024-12-12 | 2024-12-16 | $0.54 | $103K | +13.1% | -8.4% | +69.4% |
| IVVD | SELL | 2024-12-09 | 2024-12-11 | $0.60 | $289K | -22.8% | -25.9% | +38.7% |
| IVVD | SELL | 2024-05-29 | 2024-05-31 | $1.66 | $373K | -11.8% | -35.8% | -52.7% |
| ALEC | SELL | 2023-09-11 | 2023-09-13 | $6.00 | $3.0M | +13.9% | -2.1% | +8.5% |
| CYCN | SELL | 2023-08-09 | 2023-08-11 | $3.40 | $27 | -3.5% | +10.4% | -27.8% |
| ADGI | BUY | 2021-08-10 | 2021-08-12 | $17.00 | $8.5M | +3.4% | +52.1% | -29.9% |
| CYCN | BUY | 2021-06-03 | 2021-06-07 | $3.12 | $590K | +1.9% | +0.6% | -12.2% |
| SEER | BUY | 2020-12-08 | 2020-12-09 | $19.00 | $1.5M | -15.6% | -5.0% | -32.8% |
| ALEC | SELL | 2020-06-23 | 2020-06-25 | $31.54 | $276K | -14.8% | -18.0% | -60.6% |
| LYRA | SELL | 2020-05-05 | 2020-05-06 | $16.00 | $155K | -20.7% | -1.8% | -15.5% |
| LYRA | BUY | 2020-05-05 | 2020-05-06 | $16.00 | $1.0M | -20.7% | -1.8% | -15.5% |
| CYCN | BUY | 2019-04-08 | 2019-04-10 | $16.00 | $10.0M | -17.7% | -11.6% | -36.3% |
| ASNS | BUY | 2017-11-20 | 2017-11-20 | $10.00 | $5.0M | -48.9% | +0.0% | +0.0% |
| XLRN | SELL | 2016-12-08 | 2016-12-09 | $30.96 | $2.1M | -6.1% | -9.3% | +2.8% |
| XLRN | SELL | 2015-08-17 | 2015-08-26 | $30.25 | $12.3M | -30.5% | -6.3% | -6.3% |
| XLRN | SELL | 2014-05-05 | 2014-05-07 | $42.86 | $13.4M | -30.5% | -6.3% | -6.3% |
| IRWD | SELL | 2013-11-07 | 2013-11-08 | $9.11 | $19K | -8.7% | -3.1% | -3.1% |
| LOGM | SELL | 2009-07-07 | 2009-07-09 | $16.00 | $8.0M | -16.8% | -6.6% | -6.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| XLRN | 1,250 | $223K |
| ADGI | 21,374 | $99K |
| CYCN | 5,552 | $19K |
| LYRA | 7,274 | $4K |
| ASNS | 11,295 | $1K |
| DCGN | 15,842 | — |
| SIRT | 39,995 | — |
| Total | $283.2M |
Shares reported on the most recent Form 4, priced at the 2026-07-30 close. 2 holdings could not be priced and are excluded from the total.
| Scored | 5 | 5 | 5 |